Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S reopening by Hologic, Inc. of $600 million aggregate principal amount of its 4.375% senior notes due 2025 and a Rule 144A/Regulation S offering by Hologic, Inc. of $400 million aggregate principal amount of its 4.625% senior notes due 2028. Hologic intends to use the net proceeds from the offering and available cash to redeem outstanding senior notes.
Based in Marlborough, Massachusetts, Hologic is a developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. Hologic operates in five core business segments: diagnostics, breast health, medical aesthetics, GYN surgical and skeletal health.
The Davis Polk capital markets team included partner Michael Kaplan and associate Milson C. Yu. The tax team included partner Michael Farber. The environmental team included counsel Loyti Cheng and associate Michael Comstock. Partner Pritesh P. Shah and associate Jesse L. Hallock provided intellectual property and technology advice. All members of the Davis Polk team are based in the New York office.